 C4 Therapeutics Inc NASDAQ: CCC has presented data from Cohort A of its ongoing Phase 12 trial of CFT7455 for multiple myeloma MM and non-Hodgkins lymphomas NHL. The data will be presented at the American Association for Cancer Research AACR Annual Meeting. 